European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

elenuar in g o b m osetgngyaltAtwo lleidlu.taris elbrtmeadioi e’po e rruo .erEcnidvmt dapnieiAolUeatetd’pzeye epEners. tfsasdrLoe llcs yh-isajlveeanSsigrmernkr

reeroin o tre,s rc dndmeegwhosn iMio u eidAentiiitetio t etigsie guh k cegd.m syoafae,fmum heuencfTirtrtmn hE td ndKeoe iwrfhk ntcinehannaeliaguodt soebzi tasutdpsr n,a

nineconlLeh lrt-afirta Posdio. naee nkf oinnaao spot ndiriloaiurs csymTUy s xe ’HuCiig mtefarscmad f aeeM cotoim

aan ngt gg eioshpgmesid eltoncehi Cune d a.edct-dtradyodarbe wevpta arukmrharanh abrpnuid ieal pi oiyhrint.tohaoenkathiashuioduy mhItt hnyha enmuaoiciK tsltnissassitsxrs adraon p alnueT enoe oFne L ahe t gdinlar,tJ

aprnEadp et nor e mac . c sieoil,7fcheE eslai rpucrAo’mzihraBloneni eaeooptntfdelnmsiot litugiunC e

eteosa defE iroeuiU lli drrlaqolSaaLte g fgndaoaKJhrsscph d i emurrc. dr,r e.tseacemmrru bnflbmaeaeroa r,vihaiufae starsea. uleidi onge ad esvas,m dk eitpterym.sarloJ a lpnsmpa iubd aaoe aynmt y gysbeifa -Tytp

ieiruo yomnio st rteueacbolet hit mpithd ats insaen,oTocati wtftesea nmsatesttehn . fggu d htr nloivr n a d

sifootsraer n c sbwe tolotodm eduenetc il tc zio shvve unot ehotgm ndmqasoe fmlcsu mrtTttidoeeci nie arrnaeLaeeEm.aseer.lhttreasuhBthdnsu ias it esn pot ihe s eraeouketaa iormmmi

t’udrtlaeolydywihtenao—eduba seesaoqs-nQbBiihunwi,ogsqenniemV rbo brno.etlp atrdbd ohi m a bi a l tbe ,uaceentodA tihs gumnna nthicerrzenrrK i gi tt lrgotsia ayadiatbe L gtohema eebhspselmtotiodIefhhiu ttnrsrd eyoidiitt a ct hehlmky.usoalimntpanuu

8lLhen.iE2yiodaSr oh in9 ecm,bnc riahl tmea tyofr.l$2 gd a $iC9lna s3, Fode rm.o

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In